✓Isorhamnetin improved hemodynamic parameters (mPAP, RVSP) and alleviated right ventricular hypertrophy (RVHI, CSA).✓Inhibited TNF-α-induced HPASMC proliferation and inflammation.✓Upregulated BMP signaling. The gene discussed is TNF; the disease is Right ventricular hypertrophy.